Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

Clinical trial NCT04093622 · TERMINATED

Trial details

NCT number: NCT04093622
Sponsor: Fate Therapeutics
Status: TERMINATED
Study type: OBSERVATIONAL

Hematological Malignancy

Start date: 2019-10-04
Primary completion: 2020-04-09
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.